Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Francesca Piazzini"'
Autor:
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, Francesco Marzani, Laura Solmonese, Emma Bello, Fabrizio Celesti, Maria Claudia Costa, Teresa Noviello, Roberta Mortarini, Andrea Anichini, Michele Ceccarelli, Sandra Coral, Anna Maria Di Giacomo, Michele Maio, Alessia Covre, The EPigenetic Immune-oncology Consortium Airc (EPICA) investigators
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor, that is refractory to standard treatment and to immunotherapy with immune-checkpoint inhibitors (ICI). Noteworthy, melanoma brain metastases (MM-BM), that s
Externí odkaz:
https://doaj.org/article/de9304cb7f1e45d7b01e1059c5afd11b
Autor:
Mor Huri, Virginia Noferi, Irene Renda, Francesca Piazzini, Silvia Benemei, Maria Elisabetta Coccia
Publikováno v:
Frontiers in Reproductive Health, Vol 4 (2022)
BackgroundThe impact of the Coronavirus Disease-2019 (COVID-19) pandemic on pregnancy is not well-understood. During the outbreak, the initial approach suggested by the major societies was to postpone all non-urgent assisted reproductive technology (
Externí odkaz:
https://doaj.org/article/51622a5835ad4fd4ac5ec94cacbfc0bd
Autor:
Marco Reschini, Luca Pagliardini, Luca Boeri, Francesca Piazzini, Veronica Bandini, Gianfranco Fornelli, Carolina Dolci, Greta Chiara Cermisoni, Paola Viganò, Edgardo Somigliana, Maria Elisabetta Coccia, Enrico Papaleo
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
With the implementation of COVID-19 vaccine up-take, doubts regarding the impact of immunization on future fertility have begun to emerge. We have examined vaccine safety on male reproductive health. We set up a multicentre (three infertility centers
Externí odkaz:
https://doaj.org/article/ca8cf8e1de1443c5b55ba95bed46fb00
Autor:
Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre, Michele Maio
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-10 (2019)
Abstract Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check
Externí odkaz:
https://doaj.org/article/db9302128def4972b7b8e1ebf814732e
Autor:
Ornella Cutaia, Michele Maio, Luana Calabro, Alessia Covre, Carolina Fazio, Sara Cannito, Health Biology, Maria Fortunata Lofiego, Francesca Piazzini, Laura Solmonese
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/61de23d0000a4cdd84fb55fe3ea34b8a
Autor:
Maria Fortunata Lofiego, Sara Cannito, Carolina Fazio, Francesca Piazzini, Ornella Cutaia, Laura Solmonese, Francesco Marzani, Carla Chiarucci, Anna Maria Di Giacomo, Luana Calabrò, Sandra Coral, Michele Maio, Alessia Covre, on behalf of the EPigenetic Immune-Oncology Consortium Airc (EPICA) Investigators
Publikováno v:
Epigenomes, Vol 5, Iss 4, p 27 (2021)
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a severe prognosis, and with a long-standing need for more effective therapeutic approaches. However, treatment with immune checkpoint inhibitors is becoming an increasingly effect
Externí odkaz:
https://doaj.org/article/4873e483dc294f2192f580253fb9978d
Autor:
Marco Reschini, Luca Pagliardini, Luca Boeri, Francesca Piazzini, Veronica Bandini, Gianfranco Fornelli, Carolina Dolci, Greta Chiara Cermisoni, Paola Viganò, Edgardo Somigliana, Maria Elisabetta Coccia, Enrico Papaleo
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
With the implementation of COVID-19 vaccine up-take, doubts regarding the impact of immunization on future fertility have begun to emerge. We have examined vaccine safety on male reproductive health. We set up a multicentre (three infertility centers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98935cb661f51aa892b8893d2248369
https://pubmed.ncbi.nlm.nih.gov/35186854
https://pubmed.ncbi.nlm.nih.gov/35186854
Autor:
Sara Cannito, Health Biology, Ornella Cutaia, Carolina Fazio, Maria Fortunata Lofiego, Francesca Piazzini, Laura Solmonese, Luana Calabrò, Michele Maio, Alessia Covre
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Growing evidence are demonstrating the therapeutic efficacy of immune checkpoint inhibitors (ICI) in mesothelioma; however, a limited percentage of patients benefits from this therapeutic approach. Epigenetic modifications play a relevant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917cb8138227eb6d5531deed25b8f756
https://doi.org/10.1136/jitc-2020-sitc2020.0844
https://doi.org/10.1136/jitc-2020-sitc2020.0844
Autor:
Maria Fortunata Lofiego, Alfonso Cerase, Francesca Piazzini, Elisabetta Gambale, Alessia Covre, Luana Calabrò, Michele Maio, Anna Maria Di Giacomo, Monica Valente
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-10 (2019)
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-10 (2019)
Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check-point(s)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a135afac0c6f6f7f59555ad01dcfc64
http://europepmc.org/articles/PMC6798349
http://europepmc.org/articles/PMC6798349
Autor:
Giuseppe Oliveri, Maria Fortunata Lofiego, Carla Chiarucci, Elisabetta Gambale, Alessia Covre, Sara Cannito, Ornella Cutaia, Francesca Piazzini, Michele Maio, Monica Valente, Carolina Fazio, Clelia Miracco, Anna Maria Di Giacomo, Sandra Coral
Publikováno v:
Cancer Research. 80:4488-4488
Rationale: Glioblastoma multiforme (GBM) is the most common and deadliest primary brain tumour in adults, with a very dismal prognosis and limited effective therapies. Immunotherapy may play a role in treating GBM, though the initial clinical results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c13561807d2d85109e9f48ab8bacf8f
https://doi.org/10.1158/1538-7445.am2020-4488
https://doi.org/10.1158/1538-7445.am2020-4488